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INTRODUCTION
Bone marrow mesenchymal stem cells (BMSCs) are non-hematopoietic pluripotent stem cells derived from the bone marrow that are capable of differentiating into a wide variety of cells such as neuronal, cardiac, skeletal muscle, epithelial, and pancreatic islet cells (Schwartz et al. 2002 , Zhao et al. 2016 , Özdal-Kurt et al. 2016 . Bone marrow mesenchymal stem cells have been widely applied as seed cells for bone tissue engineering , Deschaseaux et al. 2010 , Kilinc et al. 2014 , liang et al. 2016 , Duan et al. 2017 . However, the ability of BMSCs to differentiate into osteoblasts is weak, which limits their clinical application in the treatment of orthopedic diseases. Thus, the key aim of the present study was to increase the differentiation ability of BMSCs. In veterinary clinics, pet fractures arising from bone disease, malnutrition, harmful (non-benign) arthropathy, and liver/kidney failure have gradually become serious obstacles affecting the quality of life and survival of pets, especially dogs and cats. Consequently, veterinary medical researchers and doctors are providing increasing attention to research around causes and possible treatments of pet fractures and/ or bone diseases. However, conventional treatments of many bone-associated diseases, especially necrotic bone diseases, are characterized by long duration and unsatisfactory treatment outcomes, as they are mainly based on surgical debridement and fixation, and self-recovery following antiinflammatory treatment. In order to improve the treatment outcome of these diseases, new methods capable of inducing the differentiation of BMSCs into osteoblasts are required. Therefore, a good understanding of the differentiation mechanisms of BMSCs is of great importance for the treatment of pet bone diseases. Since BMSCs are the source of osteoblast precursors (Pham et al. 2011 , Park et al. 2010 , Zhu et al. 2016 , their differentiation in vivo is strictly controlled in terms of time and direction by an extremely complex set of signaling molecules and pathways, such as the Wnt, transforming growth factor beta, and bone morphogenetic protein signaling pathways , Müller-Deubert et al. 2017 , long et al. 2017 . Previous research has shown that the Wnt signaling pathway plays an important role in the differentiation, proliferation, and migration of osteoblasts (ling et al. 2009 , Robinson et al. 2006 , Zhu et al. 2016 , Zhou et al. 2016 . Activation of the Wnt/β-catenin signaling pathway stimulates osteogenic differentiation (Bennett et al. 2007 , Su et al. 2015 . In addition, the enhancement of Wnt signaling either by overexpression of Wnt (Bennett et al. 2007) or shortage of Wnt antagonists (Morvan et al. 2006 , ten Dijke et al. 2008 ) increases bone formation in humans and mice. Moreover, Wnt signaling promotes the differentiation of mouse mesenchymal stem cells (MSCs) towards the osteoblastic lineage (gaur et al. 2005) . 6-Bromoindirubin-3'-oxime (BIO), a specific inhibitor of glycogen synthase kinase 3 beta (GSK3β), is known to activate the Wnt/β-catenin signaling pathway (Meijer et al. 2003 , Sato et al. 2004 . In this study, we mimicked the effect of Wnt by adding BIO to canine BMSCs and investigated whether canonical Wnt signaling positively affects the differentiation of these cells into osteoblasts.
MATERIALS AND METHODS

MATeRIAlS
Chemicals were obtained from Sigma-Aldrich Chemical (St.louis, MO, USA) unless otherwise specified.
BMSCs ISOlATION AND CUlTURe
The current protocol for experimentation on beagle dogs (two-months-old, 1.5 kg, obtained from Wu gong County) was approved by the Institutional Animal Care and Use Committee of Northwest A&F University. Dogs were injected with 10 mg/ kg ketamine. Then, 10 ml of the bone marrow was extracted from the iliac crest of each dog under sterile conditions according to previously reported methods (Sun et al. 2010) . To obtain BMSCs, bone marrow cells were incubated in culture dishes (diameter, 60 mm) with 4 ml of alpha minimum essential medium (α-MEM, Gibco) containing 10% fetal bovine serum (FBS, gibco) and 100 U/ml penicillin/streptomycin (North China Pharmaceutical Co., ltd., Shijiazhuang, China). Cultures were maintained at 37 °C and 5% CO 2 . After 24 h, non-adherent cells were removed by replacing the medium with fresh α-MEM containing 10% FBS. The medium was replaced with fresh medium every 3 d. When cells reached 80-90% confluence, the medium was discarded, and 0.5 ml of 0.1% trypsin (Sigma) was added for 2 min at room temperature. Trypsin was neutralized by the addition of α-MEM containing 10% FBS, and the analyzed by paired Student's t-test relative to cells grown in basic medium without BIO.
JC-1 assay: P3 BMSCs were treated as described above. After 4 d, a JC-1 apoptosis detection kit (Keygen) was used to measure the mitochondrial transmembrane potential (Δψm). After washing, the JC-1 working solution was added to each well, and cells were incubated at 37 °C and 5% CO 2 for 20 min, then the nuclei were stained with Hoechst33342 (Sigma, USA) for 5 min at room temperature. After washing with PBS, the images were captured using a fluorescence microscope (Olympus, Tokyo, Japan).
AlKAlINe PHOSPHATASe STAININg P3 BMSCs were seeded at a density of 5 × 10 4 cells/ ml into 35-mm dishes (1 ml/ dish) with osteogenic medium containing different concentrations (0, 0.5 and 1.0 μM) of BIO for 5 d. Alkaline phosphatase (AlP) activity was determined using an AlP kit (Nanjing Jiancheng Bioengineering Institute). The cells were washed 3 times with PBS, then fixed with 4% formaldehyde (Sigma, USA) for 30 min and washed with PBS again. Cells were stained with the ALP reagent [33 μL BCIP (300×) and 66 μL NBT (150×) were added to the alkaline phosphatase staining buffer] for 1-2 h at room temperature, then images were captured using an inverted microscope (Olympus, Tokyo, Japan), and the number of positive cells was obtained by randomly counting the number of positive cells in 3 fields of vision, repeating 3 times and averaging.
AlIZARIN ReD STAININg P3 BMSCs were seeded at a density of 1 × 10 4 cells/ml into 35-mm dishes (1 ml/ dish) for each group. After attachment, cells were cultured with an osteogenesis-inducing medium with or without BIO. On day 14, the cells were washed 3 times with PBS, fixed with 95% ethanol for 10 min, dried at room temperature, and then stained with 0.1% cell suspension was centrifuged at 1000 × g for 6 min. Then, the supernatant was discarded, and the cells were resuspended and passaged at 1:3 ratio. To determine the BIO concentration needed to stimulate osteogenic differentiation of canine BMSCs, P3 BMSCs were cultured with different concentrations of BIO, and its effect on the cells was analyzed by cell proliferation detection and JC-1 assay. Cell proliferation detection: P3 BMSCs were seeded at a density of 5.0 × 10 4 cells/ml into 24-well plate (400 µl/well) in osteogenic medium containing (control group), and osteogenic medium containing 0.5, 1.0, and 2.5 μM BIO. After 4 d, cells were counted using a red blood cell count plate (Qiujing, China) and proliferation was expressed as the number of population doublings per day (PDD). Average PDD values for each BIO concentration were calculated and results were XIAO-e ZHAO et al.
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Alizarin Red (pH 4.2; Sigma, USA) for 1-2 h at room temperature. Then, the Alizarin Red solution was removed, and cells were rinsed with PBS and dried at room temperature. Images were captured using an inverted microscope (Olympus, Tokyo, Japan).
IMMUNOFlUOReSCeNCe STAININg P3 BMSCs were seeded at a density of 5 × 10 4 cells/ ml into 35-mm dishes (1 ml/ dish) with osteogenic medium containing different concentrations (0, 0.5 and 1 μM) of BIO for 4 d. Then, β-catenin was detected by immunofluorescence (IF) staining as follows: After discarding the culture medium, cells were washed 3 times with PBS and fixed with 4% paraformaldehyde (Sigma) for 1 h at room temperature, then washed 3 times with PBS again. The cells were dialyzed against 0.2% triton X-100 (Sigma, USA) for 10 min at room temperature, then washed 3 times with PBS and blocked with 1% bovine serum albumin (BSA, Sigma) in PBS at 4 °C for 1 h. After washing and draining, the cells were incubated overnight at 4 °C with the β-catenin primary antibody (1:100, Abcam, UK), washed 3 times with PBS, incubated with secondary donkey anti-rabbit antibody (1:100, Santa Cruz, USA) at 37 °C for 1 h, and then washed 3 times with PBS again. The nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI) (Sigma, USA) for 2 min at room temperature. After washing with PBS, the images were captured using a fluorescence microscope (Olympus, Tokyo, Japan).
WeSTeRN BlOT ANAlYSIS P3 BMSCs were seeded at a density of 5 × 10 4 cells/ ml into 35-mm dishes (1 ml/ dish) with osteogenic medium containing different concentrations (0, 0.5 and 1 μM) of BIO. After 6 h, GSK3β and phosphorylated GSK3β (p-GSK3β) were detected by western blotting, while β-catenin was detected after 4 d, also by western blotting. Cells were lysed with radioimmunoprecipitation assay buffer (CW Bio, China) and protein concentrations were determined using the BCA Protein Assay Kit (Heart, China All collected data were entered in a Microsoft excel sheet after generation of a proper template, and were calculated and analyzed by SPSS software (version 18.0) (International Business Machines (IBM) Corporation, New York, USA).
RESULTS
PHeNOTYPe CHARACTeRIZATION
Canine BMSCs were analyzed for their cell surface antigens by flow cytometry (Figure 1) . Our results showed that isolated BMSCs were strongly positive for CD105 and CD90, which are specific antigens for non-hematopoietic bone marrow progenitor cells, and were negative for CD34 and CD45, which are common markers of hematopoietic and endothelial cells (Tuli et al. 2003 ). These results demonstrate the immunophenotypic MSC characteristics of canine BMSCs.
eFFeCT OF BIO ON BMSCs PROlIFeRATION
As shown in Figure 2 , treatment of canine BMSCs with 0.5 and 1.0 μM BIO slightly inhibited their proliferation (Figure 2a, b) . The antiproliferative activity of BIO was dramatically enhanced at the concentration of 2.5 μM, as cells treated with 2.5 μM BIO showed slow proliferation and demonstrated significant morphological changes; most of them became irregularly circular and hypertrophic (Figure 2a, b) . even though a small fraction of the cells still maintained their fibroblast morphology on day 4, their shapes changed and became shorter and thicker. The control group demonstrated normal fibroblast morphology on day 4 (Figure 2b ).
The Δψm of the BMSCs was determined by JC-1 staining (Figure 2c ). Strong red and weak green fluorescent signals were detected in osteogenic media containing 0, 0.5, and 1.0 μM BIO, while the osteogenic medium containing 2.5 μM BIO demonstrated relatively strong green and relatively weak red fluorescent signals. The significant decrease in the fluorescence intensity of the red signals in the 2.5 μM BIO group compared to the other groups indicates a decrease in the Δψm in this group. Based on the results of the cells proliferation and JC-1 staining assays, 0.5 and 1.0 μM were selected as the optimal BIO concentrations.
BIO eNHANCeD THe DIFFeReNTIATION OF CANINe BMSCs INTO OSTeOBlASTS
The incubation of canine BMSCs with various concentrations of BIO for 5 d resulted in an increase in the activity of AlP (Figure 3a, b) , which is a marker enzyme for osteoblasts. As shown in Figure 3 , treatment with 0.5 and 1.0 μM BIO significantly increased the number of ALP-positive BMSCs (Figure 3a, b) , with 1.0 μM BIO exhibiting a stronger effect than 0.5 μM BIO. Moreover, treatment with 0.5 and 1.0 μM BIO for 14 d resulted in an increase in the mineralization level XIAO-e ZHAO et al.
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An Acad Bras Cienc (2019) 91 (1) e20180459 6 | 14 BIO under osteogenic conditions for 6 h. Then, GSK3β and p-GSK3β levels were determined by western blotting. Our results showed that GSK3β phosphorylation was significantly upregulated by BIO treatment, and that p-GSK3β levels in cells treated with 1.0 μM BIO were slightly higher than in cells treated with 0.5 μM BIO ( Figure 5 ). These results indicate that BIO inhibits GSK3β activity, suggesting that GSK3β is the target of BIO for enhancing osteogenesis. To investigate the effect of BIO on osteoblast differentiation, canine BMSCs were incubated with 0, 0.5, and 1.0 μM BIO for 3, 7, and 14 d, and control cells. Moreover, markers of late osteoblast differentiation, OCN and ONN, were found to be strongly expressed in BMSCs treated with 0.5 and 1.0 μM BIO for 14 d. All these results indicate that BIO can promote the ability of canine BMSCs to differentiate into osteoblasts.
DISCUSSION
Previous research has shown that the Wnt signaling pathway plays an important role in the differentiation, proliferation, and migration of stem cells (ling et al. 2009 , Robinson et al. 2006 , Zhu et al. 2016 , Zhou et al. 2016 et al. , Anton et al. 2007 ) is important for the maintenance of pluripotency and self-renewal in human and mouse embryonic stem cells (Hur and Zhou 2010, Meijer et al. 2003) , and for the modulation of apoptosis (Chon et al. 2015) . In this study, we added different concentrations of BIO to BMSCs and examined whether the stimulation of canonical Wnt signaling by BIO positively affects the differentiation of these cells into osteoblasts. First, we found that 2.5 μM BIO inhibited the proliferation of BMSCs, thus, lower concentrations (0.5 and 1 µM BIO) were selected to be used in the experiments.
Osteogenic differentiation of BMSCs is the most important process in bone formation and reconstruction and is regulated by multiple signaling pathways (lee et al. 2016 , Zhou et al. 2016 , Tang et al. 2016 . The classic Wnt/β-catenin signaling pathway is one of the key pathways that regulate bone formation and promote bone differentiation (Qian et al. 2015 . The Wnt/β-catenin signaling pathway Co., ltd., China) was used to determine the gray values of the internal reference (β-actin) proteins and p-GSK3β protein bands, and the ratios were used as the relative expression of proteins. Calculating p-GSK3β relative expression and averaging. Error bars denote mean ± SD. *P < 0.05. Control: osteogenic medium; 0.5 and 1.0 μM BIO: osteogenic medium containing 0.5 and 1.0 μM BIO. the expression levels of osteoblast differentiation markers, such as RUNX2, ALP, COI, ONN, and OCN were examined by RT-PCR. As shown in Figure 6 , COI and RUNX2 expression levels were evidently increased in cells treated with 0.5 and 1.0 μM BIO for 3, 7, and 14 d. Moreover, the expression of ALP, a marker of early osteoblast differentiation, was evidently increased in cells treated with 0.5 and 1.0 μM BIO for 3 and 7 d. However, cells cultured with BIO for 14 d showed lower relative mRNA expression of ALP than functions by regulating β-catenin phosphorylation and degradation in the cytoplasm. Upon activation of the canonical Wnt pathway, inhibition of GSK3β results in the dephosphorylation of β-catenin leading to its accumulation in the nucleus. In this study, we investigated the effects of BIO on the Wnt/β-catenin signaling pathway, and on the differentiation of canine BMSCs. Our results demonstrated that BIO treatment resulted in β-catenin upregulation and nuclear translocation, which indicates that BIO could activate Wnt/β-catenin signaling in canine BMSCs. Moreover, we found that BIO can robustly stimulate canine BMSCs differentiation; 0.5 and 1.0 μM BIO successfully enhanced the differentiation of canine BMSCs into osteoblasts. Furthermore, we investigated the direct inhibitory effect of BIO on GSK3β by western blot analysis, which demonstrated an upregulation in p-GSK3β levels in BIO-treated cells, indicating that the BIOinduced activation of Wnt/β-catenin signaling in canine BMSCs is mediated by inhibition of GSK3β activity.
The effect of the Wnt pathway on osteogenesis depends on both the cellular environment and the expression of target genes (liu et al. 2013 ). Thus, we investigated the expression of osteoblast differentiation markers such as RUNX2, COI, ALP, ONN, and OCN, and found that they were increased in cells treated with BIO. RUNX2 activates and induces the differentiation of BMSCs into immature osteoblasts and regulates pre-osteoblast maturation. It also directly stimulates the transcription of OCN and COI during the differentiation of BMSCs into osteoblasts (Ducy et al. 1999, Okazaki and Sandell 2004) . COI is the basis for the formation of calcium nodules (Owen et al. 1990) , ALP activity is a useful early detector for features of osteogenesis, and OCN is a late marker of osteogenic differentiation (Maroni et al. 2012) . Our results showed that, compared with the control cells, BIO-treated cells exhibited an evident increase in the relative mRNA expression of RUNX2 and COI. In addition, relative mRNA expression of ALP was evidently increased in cells treated with BIO for 3 and 7 d, while it was decreased in cells treated with BIO for 14 d. Moreover, OCN and ONN, markers of late osteoblast differentiation, were strongly expressed in BMSCs treated with BIO for 14 d compared to untreated cells, which indicates the formation of mature osteoblasts from canine BMSCs treated with BIO for 14 d. Alizarin Red staining proved osteoblast formation and matrix mineralization in BIO-treated cells on day 14, while it demonstrated their absence in the control cells. Collectively, all of the aforementioned results prove that BIO could increase the differentiation ability of BMSCs into osteoblasts through regulation of the target genes of β-catenin signaling.
CONCLUSIONS
Treatment of canine BMSCs with BIO resulted in upregulation of GSK3β phosphorylation, and thus inhibition of GSK3β activity and activation of Wnt/β-catenin signaling, consequently leading to accumulation of β-catenin in the cytoplasm and its translocation into the nucleus, where it induced the expression of downstream target genes and osteoblast differentiation markers. In conclusion, BIO-mediated activation of the canonical Wnt/β-catenin signaling pathway can increase the ability of canine BMSCs to differentiate into osteoblasts.
